Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Exposure-Response Evaluation of IV Artesunate in Children With Severe Malaria
NCT05750459Phase 4Completed
- Sponsor
- National Institute of Allergy and Infectious Diseases
- Start
- Nov 2023
- Primary completion
- Apr 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of artesunate in Plasmodium falciparum malaria, sponsored by National Institute of Allergy and Infectious Diseases. Started Nov 2023; status: completed.
02
Drugs
artesunate
03
Conditions
Plasmodium falciparum malaria
Beyond the preview
Go deeper on NCT05750459.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05750459.